• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机对照试验比较 35%三氯乙酸剥脱术和 5-氨基酮戊酸光动力疗法治疗多发性光化性角化病。

Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.

机构信息

Department of Dermatology, Medical University of Vienna, Vienna, SMZ Ost, 122, Langobardenstrasse, 1220, Vienna, Austria.

Department of Dermatology, Donauspital, SMZ Ost Vienna, Vienna, Austria.

出版信息

Br J Dermatol. 2017 May;176(5):1155-1161. doi: 10.1111/bjd.15272. Epub 2017 Apr 5.

DOI:10.1111/bjd.15272
PMID:28012181
Abstract

BACKGROUND

Photodynamic therapy (PDT) and chemical peels with trichloroacetic acid (TCA) can be applied to large skin areas and thus are suitable treatment options for patients with multiple actinic keratosis (AK). However, despite its long use, TCA has been investigated only rarely in this indication.

OBJECTIVES

This randomized, observer-blinded, intrapatient comparative study sought to investigate the efficacy and safety of 35% TCA vs. aminolaevulinic acid 20% (ALA) PDT in patients with extensive field cancerization and multiple AKs in the face or on the scalp.

METHODS

Twenty-eight patients with at least five AKs in two comparable anatomical areas on the head were treated with 35% TCA and ALA PDT randomly assigned to each area. Their therapeutic efficacy, adverse events and cosmetic outcome were assessed by a blinded investigator at 1, 3, 6 and 12 months after treatment.

RESULTS

After 12-months' follow-up TCA and ALA PDT reduced the total lesion count, the primary outcome, by 31% and 58%, respectively (P = 0·006). Complete clearance of pre-existing AKs were 49% for TCA and 74% for ALA PDT (P = 0·011). Treatment failure (number of AKs greater than 50% of the baseline count) was observed in seven patients (25%) after TCA and in two patients (7%) after PDT treatment. Treatment-related pain was significantly higher for ALA PDT (visual analogue scale 7·5 ± 2·3 vs. TCA: 5·1 ± 2·6; P = 0·04), whereas scarring (n = 6, 21%) was seen only in TCA treated patients.

CONCLUSIONS

ALA PDT provided better clinical results than TCA in the treatment of patients with extensive field cancerization and multiple AKs.

摘要

背景

光动力疗法(PDT)和三氯乙酸(TCA)化学焕肤可用于大面积皮肤,因此是患有多发性光化性角化病(AK)患者的合适治疗选择。然而,尽管 TCA 已使用多年,但针对这种适应证,对其研究甚少。

目的

本随机、观察者设盲、患者内比较研究旨在比较 35%TCA 与 20%氨基酮戊酸(ALA)PDT 治疗面部和头皮大面积光化性角化病和多发性 AK 的疗效和安全性。

方法

28 例患者头部两个相似解剖区域均至少有 5 个 AK,随机将患者分为两组,分别接受 35%TCA 和 ALA PDT 治疗。治疗后 1、3、6 和 12 个月,由盲法研究者评估其疗效、不良反应和美容效果。

结果

12 个月随访时,TCA 和 ALA PDT 分别使总皮损计数(主要结局)减少 31%和 58%(P=0.006)。TCA 和 ALA PDT 完全清除已存在 AK 的比例分别为 49%和 74%(P=0.011)。TCA 组有 7 例(25%)和 ALA PDT 组有 2 例(7%)患者治疗失败(AK 数量多于基线计数的 50%)。ALA PDT 治疗相关疼痛明显高于 TCA(视觉模拟评分 7.5±2.3 比 TCA:5.1±2.6;P=0.04),而 TCA 组仅 6 例(21%)患者出现瘢痕。

结论

ALA PDT 治疗大面积光化性角化病和多发性 AK 的临床疗效优于 TCA。

相似文献

1
Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.随机对照试验比较 35%三氯乙酸剥脱术和 5-氨基酮戊酸光动力疗法治疗多发性光化性角化病。
Br J Dermatol. 2017 May;176(5):1155-1161. doi: 10.1111/bjd.15272. Epub 2017 Apr 5.
2
Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.日光光动力疗法治疗光化性角化病:一项比较 5-氨基酮戊酸纳米乳剂 (BF-200) 与甲氧基 5-氨基酮戊酸的随机双盲非对照前瞻性研究。
Br J Dermatol. 2014 Nov;171(5):1172-80. doi: 10.1111/bjd.13326. Epub 2014 Oct 15.
3
Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.一项随机、双盲、前瞻性研究,比较外用5-氨基乙酰丙酸甲酯与外用5-氨基乙酰丙酸光动力疗法治疗广泛性头皮光化性角化病的效果。
Br J Dermatol. 2007 Jul;157(1):87-91. doi: 10.1111/j.1365-2133.2007.07946.x. Epub 2007 May 14.
4
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.日光光动力疗法联合氨甲环酸乳膏作为一种方便、同样有效的、几乎无痛苦的替代传统光动力疗法治疗光化性角化病的方法:一项随机对照试验。
Br J Dermatol. 2014 Nov;171(5):1164-71. doi: 10.1111/bjd.13138. Epub 2014 Oct 20.
5
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.使用氨基乙酰丙酸对面部和头皮非角化过度性光化性角化病患者进行光动力疗法:一项为期12个月随访的IV期多中心临床试验。
Br J Dermatol. 2006 Dec;155(6):1262-9. doi: 10.1111/j.1365-2133.2006.07520.x.
6
A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.一项比较卡泊三醇辅助氨甲环酸光动力疗法(MAL-PDT)与常规 MAL-PDT 治疗光化性角化病的随机头皮分裂研究。
Br J Dermatol. 2018 Oct;179(4):829-835. doi: 10.1111/bjd.16473. Epub 2018 May 15.
7
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.光动力疗法比咪喹莫特治疗器官移植受者光化性角化病更有效:一项随机个体对照试验。
Br J Dermatol. 2018 Apr;178(4):903-909. doi: 10.1111/bjd.15884. Epub 2018 Feb 5.
8
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.外用甲基氨基乙酰丙酸乳膏的日光光动力疗法治疗光化性角化病有效且几乎无痛:一项在全欧洲开展的随机、研究者设盲、对照、III期研究。
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2342-8. doi: 10.1111/jdv.13228. Epub 2015 Oct 5.
9
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.光动力疗法联合 BF-200 ALA 治疗光化性角化病:一项多中心、随机、观察者盲法 III 期研究结果,与上市的甲氨基酮戊酸乳膏和安慰剂比较。
Br J Dermatol. 2012 Jan;166(1):137-46. doi: 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.
10
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.光动力疗法治疗额部和头皮光化性角化病:一项随机、对照、二期临床研究,评估一种新方案(Flexitheralight 方案,涉及使用发光织物设备进行辐照)与传统方案(涉及使用 Aktilite CL 128 灯进行辐照)的非劣效性。
Br J Dermatol. 2019 Apr;180(4):765-773. doi: 10.1111/bjd.17350. Epub 2019 Jan 18.

引用本文的文献

1
TCA chemical peel as facial anti-aging therapy for postmenopausal women: a randomised clinical study.三氯乙酸化学剥脱术作为绝经后女性面部抗衰治疗:一项随机临床研究
Postepy Dermatol Alergol. 2025 Feb;42(1):28-41. doi: 10.5114/ada.2024.144161. Epub 2024 Oct 12.
2
Treatment of actinic keratosis: a systematic review.光化性角化病的治疗:系统评价。
Arch Dermatol Res. 2023 Jul;315(5):1099-1108. doi: 10.1007/s00403-022-02490-5. Epub 2022 Dec 1.
3
Wounding Therapies for Prevention of Photocarcinogenesis.预防光致癌的创伤疗法
Front Oncol. 2022 Jan 7;11:813132. doi: 10.3389/fonc.2021.813132. eCollection 2021.
4
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.使用10% 5-氨基酮戊酸凝胶和红光进行光动力疗法治疗光化性角化病、非黑素瘤皮肤癌和痤疮:当前证据与最佳实践
J Clin Aesthet Dermatol. 2021 Oct;14(10):E53-E65.
5
Trichloroacetic Acid Peeling for Treating Photoaging: A Systematic Review.三氯乙酸剥脱术治疗光老化:一项系统评价
Dermatol Res Pract. 2021 Aug 30;2021:3085670. doi: 10.1155/2021/3085670. eCollection 2021.
6
Guidelines of care for the management of actinic keratosis: Executive summary.光化性角化病管理指南:执行摘要。
J Am Acad Dermatol. 2021 Oct;85(4):945-955. doi: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7.
7
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
8
Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.光化性角化病与场癌化治疗的管理要点
Dermatol Ther (Heidelb). 2020 Oct;10(5):903-915. doi: 10.1007/s13555-020-00425-4. Epub 2020 Jul 17.
9
Chemical Peels in Skin Cancer: A Review.皮肤癌中的化学剥脱术:综述
J Clin Aesthet Dermatol. 2020 Feb;13(2):53-57. Epub 2020 Feb 1.
10
Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.光化性角化病和皮肤鳞状细胞癌。
Dtsch Arztebl Int. 2019 Sep 13;116(37):616-626. doi: 10.3238/arztebl.2019.0616.